At The Mark Sommerville Foundation, we can not wait for the government or big charities to take the lead. When promising trials get held back by the lack of funding, we take the matters into our own hands, to ensure that the current patients get a chance of living to see potential treatments.

Recently, we met with the team from Nevrargenics, and with their lead scienitst Andy Whiting, we identified that it would take only £350,000 to ensure that human trials for Ellorarxine, by Nevrargenics take place this year 2025, and that the trials would be brought forward some 3 months, even. We are currently raising money for this purpose on Just Giving. Please help us make a difference..